ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

ClinicalTrials.gov ID: NCT01415908

Public ClinicalTrials.gov record NCT01415908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-center, Pivotal Trial for INFUSE® Bone Graft With CAPSTONE® Spinal System and Posterior Supplemental Fixation to Treat 1- or 2-level Advanced Degenerative Disease of the Lumbosacral Spine For a TLIF Approach

Study identification

NCT ID
NCT01415908
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medtronic Spinal and Biologics
Industry
Enrollment
15 participants

Conditions and interventions

Interventions

  • INFUSE Bone Graft Device
  • Iliac Crest Bone Graft Other

Device · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2011
Primary completion
Aug 31, 2014
Completion
Dec 31, 2014
Last update posted
Feb 17, 2016

2011 – 2015

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Sonoran Spine Center Mesa Arizona 85202
USC Department of Neurological Surgery Los Angeles California 90033
Andrews Institute Gulf Breeze Florida 32561
Fort Wayne Orthopaedics Fort Wayne Indiana 46804
UPMC Presbyterian Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01415908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2016 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01415908 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →